Isolation and characterization of type IV group B Streptococcus capsular polysaccharide
- PMID: 2494110
- PMCID: PMC313234
- DOI: 10.1128/iai.57.4.1089-1094.1989
Isolation and characterization of type IV group B Streptococcus capsular polysaccharide
Abstract
An antigenically distinct serotype, type IV, has recently been added to the recognized serotypes of group B streptococci (GBS). We isolated and purified the capsular polysaccharide antigen from a prototype type IV GBS strain. The type IV capsular polysaccharide formed a precipitin line with rabbit antiserum to type IV GBS organisms but not with antiserum to organisms of GBS serotype Ia, Ib, II, or III. Enzyme-linked immunosorbent assay inhibition experiments showed no cross-reaction between type IV antiserum and other GBS serotypes. Capsular polysaccharide released from the bacterial cells with mutanolysin and that isolated from the culture supernatant had similar elution profiles on Sepharose CL-6B, with a Kav of 0.30 and an estimated Mr of 200,000. The purified type IV polysaccharide was found to contain galactose, glucose, N-acetylglucosamine, and N-acetylneuraminic acid (sialic acid) as exclusive sugars. The polysaccharide contained 23% (by weight) sialic acid and galactose, glucose, and N-acetylglucosamine in a relative ratio of (1):1.10:0.55. These results are compatible with a repeating structure of six monosaccharide residues containing galactose, glucose, N-acetylglucosamine, and sialic acid in a molar ratio of 2:2:1:1. Unlike type Ia, II, and III GBS polysaccharides, desialylation of the type IV polysaccharide produced an antigen which formed a line of identity with the native type IV antigen in double diffusion in agar against homologous antiserum. This result suggests that sialic acid is not as critical to the immunodeterminant structure of the type IV antigen as it is for other GBS capsular types.
Similar articles
-
Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).Infect Immun. 1993 Apr;61(4):1272-80. doi: 10.1128/iai.61.4.1272-1280.1993. Infect Immun. 1993. PMID: 8454331 Free PMC article.
-
Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide.J Clin Invest. 1983 Jul;72(1):260-9. doi: 10.1172/jci110965. J Clin Invest. 1983. PMID: 6192144 Free PMC article.
-
Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.J Med Microbiol. 1999 Nov;48(11):983-990. doi: 10.1099/00222615-48-11-983. J Med Microbiol. 1999. PMID: 10535641
-
Immunochemical characterization of the polysaccharide antigens of group B streptococci.Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S367-71. doi: 10.1093/cid/10.supplement_2.s367. Rev Infect Dis. 1988. PMID: 3142018 Review.
-
Glycoconjugate vaccines to prevent group B streptococcal infections.Expert Opin Biol Ther. 2003 Sep;3(6):975-84. doi: 10.1517/14712598.3.6.975. Expert Opin Biol Ther. 2003. PMID: 12943456 Review.
Cited by
-
Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.J Clin Invest. 1990 Nov;86(5):1428-33. doi: 10.1172/JCI114858. J Clin Invest. 1990. PMID: 2243123 Free PMC article.
-
Characterization of Shigella dysenteriae type 1 capsular polysaccharide by immunochemical methods.Folia Microbiol (Praha). 1998;43(6):707-12. doi: 10.1007/BF02816395. Folia Microbiol (Praha). 1998. PMID: 10069017
-
The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon.J Bacteriol. 2000 Aug;182(16):4466-77. doi: 10.1128/JB.182.16.4466-4477.2000. J Bacteriol. 2000. PMID: 10913080 Free PMC article.
-
Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.J Clin Microbiol. 2017 Sep;55(9):2637-2650. doi: 10.1128/JCM.00300-17. Epub 2017 Jun 14. J Clin Microbiol. 2017. PMID: 28615470 Free PMC article.
-
L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway.Infect Immun. 2008 Jan;76(1):179-88. doi: 10.1128/IAI.00837-07. Epub 2007 Oct 15. Infect Immun. 2008. PMID: 17938215 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources